Pharmaceuticals, Biotechnology and Life Sciences
Don't spend too much on your repeated translations.
Cut costs with Vikler Media. Visit: media.vikler.net
Secarna to collaborate with Scenic to develop first-in-class disease-modifying oligonucleotide therapies for severe genetic diseases.
Bristol Myers Squibb and Bain Capital announced Monday the creation of a new independent biopharmaceutical company, called NewCo, which will be focused on developing new therapies for autoimmune diseases that...
Micrima, a Bristol-based health tech company, is urging women to give themselves the gift of prioritising knowledge of their breast density this Christmas. Dense breast tissue is a relatively unknown but common breast cancer risk factor, which additionally makes it...
Brenntag, the global market leader in chemicals and ingredients distribution, held a celebration to mark its 150-year anniversary yesterday in...
Over-65s across the UK are set to benefit from potentially life-changing new treatment options for conditions like cancer and cardiovascular...
DUBLIN–(BUSINESS WIRE)–The “Rare Diseases Treatment Market – Global Forecast 2025-2032” report has been added to ResearchAndMarkets.com’s offering. The rare diseases…
DUBLIN–(BUSINESS WIRE)–The “Orphan Drugs Market – Global Forecast 2025-2032” report has been added to ResearchAndMarkets.com’s offering. Senior leaders in the…
Sermo Barometer reveals shifting access pathways, evolving prescribing behavior, and long-term impacts on patient care. NEW YORK–(BUSINESS WIRE)–The 43rd Barometer…
Return of approximately $500 million – maximum approved by shareholders – set to be completed on January 7, 2026 Capital…
LEOBENDORF, Austria–(BUSINESS WIRE)–#aestheticmedicine–Croma-Pharma, a global player in minimally invasive aesthetic medicine, proudly announces the launch of its new medical device…
HANGZHOU, China–(BUSINESS WIRE)–Qihan Biotech, a clinical-stage biotechnology company developing off-the-shelf cell therapies for autoimmune diseases and cancer, including allogeneic CAR-T…
NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of…
CAMBRIDGE, Mass. & SAN DIEGO–(BUSINESS WIRE)–Quantori, a leading provider of digital transformation services and technology for the life sciences and…
VANCOUVER, British Columbia–(BUSINESS WIRE)–$ABCL—AbCellera (Nasdaq: ABCL) today announced that it has entered into a settlement and patent license agreement with…
AUSTIN, Texas–(BUSINESS WIRE)–Ollin Biosciences, Inc. (Ollin), a clinical-stage biopharmaceutical company dedicated to acquiring and developing best-in-disease therapies for vision-threatening diseases,…
